Citation: | DING Zhiying, YI Chunbei, NIE Chenlei, ZHA Hailing, LI Cuiying. Analysis of pathological underestimation of breast lesions by ultrasound-guided core needle biopsy[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 1-4. DOI: 10.7619/jcmp.202023001 |
范春妮. 超声引导下粗针穿刺活检在乳腺微小病变(最大径≤5 mm)诊断中的价值[D]. 吉林: 吉林大学, 2011.
|
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志, 2019, 29(8): 609-679.
|
HOUSSAMI N, CIATTO S, ELLIS I, et al. Underestimation of malignancy of breast core-needle biopsy[J]. Cancer, 2007, 109(3): 487-495.
|
杨后圃, 郭嘉嘉, 谢菲, 等. 两种微创活检手段在高度可疑恶性乳腺肿块术前诊断中的价值[J]. 中华普通外科杂志, 2016, 31(1): 32-35.
|
BRUENING W, FONTANAROSA J, TIPTON K, et al. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions[J]. Ann Intern Med, 2010, 152(4): 238-246.
|
禹雪. 超声引导空芯针穿刺活检在乳腺结节中的诊断价值[J]. 中国微创外科杂志, 2019, 19(6): 544-547.
|
YOON J H, KIM M J, MOON H J, et al. Subcategorization of ultrasonographic BI-RADS category 4: positive predictive value and clinical factors affecting it[J]. Ultrasound Med Biol, 2011, 37(5): 693-699.
|
孙立, 朱玉兰, 汤黎明. 空芯针穿刺活检在超声BI-RADS 4级乳腺病灶性质诊断中的应用[J]. 山东医药, 2018, 58(34): 71-74.
|
CHANG J M, MOON W K, CHO N, et al. Management of ultrasonographically detected benign papillomas of the breast at core needle biopsy[J]. Am J Roentgenol, 2011, 196(3): 723-729.
|
YOUK J H, KIM E K, KWAK J Y, et al. Benign Papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy[J]. Radiology, 2011, 258(1): 81-88.
|
HSU H H, YU J C, HSU G C, et al. Atypical ductal hyperplasia of the breast diagnosed by ultrasonographically guided core needle biopsy[J]. Ultraschall Med, 2011, 33(5): 447-454.
|
YOUK J H, KIM E K, KIM M J. Atypical ductal hyperplasia diagnosed at sonographically guided 14-gauge core needle biopsy of breast mass[J]. Am J Roentgenol, 2009, 192(4): 1135-1141.
|
KUHL C K, SCHRADING S, BIELING H B, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study[J]. Lancet, 2007, 370(9586): 485-492.
|
CASWELL-SMITH P, WALL M. Ductal carcinoma in situ: Is core needle biopsy ever enough[J]. J Med Imaging Radiat Oncol, 2017, 61(1): 29-33.
|
MARION S, SAVITRI K, LUMARIE S, et al. Lobular Carcinoma In Situ of the Breast[J]. Academic Radiology, 2013, 20(4): 463-470.
|
孙琨, 严福华, 陈克敏, 等. 乳腺小叶原位癌的X线和超声及MRI表现[J]. 放射学实践, 2014, 29(10): 1120-1122.
|
朱勐, 彭玉兰, 马步云, 等. 乳腺小叶原位癌与小叶非典型增生的高频超声特征分析[J]. 四川大学学报: 医学版, 2017, 48(2): 302-305.
|
王春华, 姚建国, 于亚威, 等. 乳腺麦默通微创旋切标本1 362例术中冷冻切片检查分析[J]. 浙江医学, 2017, 39(4): 296-297
, 303.
|
朱晓萍, 朱娟英, 唐婕, 等. 麦默通微创旋切系统在乳房肿块切除中的应用: 附7079例乳房病灶手术病理结果[J]. 实用肿瘤杂志, 2018, 33(1): 81-85.
|
FARSHID G, DOWNEY P, PIETERSE S, et al. Effectiveness of core biopsy for screen-detected breast lesions under 10 mm: implications for surgical management[J]. ANZ J Surg, 2017, 87(9): 725-731.
|
[1] | SHI Lihui, ZHANG Teng, LIANG Qiu, MEI Lijuan. Correlations of peripheral blood inflammatory and immune-related indicators with clinicopathological features and prognosis in breast cancer patients[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 75-79. DOI: 10.7619/jcmp.20245649 |
[2] | WEN Xuzhi, XU Chunni, HONG Guobiao, LUO Xuexin, CHEN Wenwei. Correlation between the pulmonary immune prognostic index and prognosis of advanced non-small cell lung cancer patients treated with sintilimab[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 17-21, 29. DOI: 10.7619/jcmp.20242691 |
[3] | CAO Xiaohua, DU Fengming, HU Chaoyang, SUN Yan. Construction of a prognostic model for hepatocellular carcinoma based on immune and metabolism related genes and drug prediction[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 27-35, 41. DOI: 10.7619/jcmp.20241305 |
[4] | YANG Jingjing, GUO Huaijuan, MAO Jingxian, WANG Jiaxin, WANG Ying, YAN Xuebing, PAN Xiaoping. Construction and validation of a risk model for colorectal cancer prognosis based on N6-methyladenosine modification and immune infiltration[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 1-8. DOI: 10.7619/jcmp.20240201 |
[5] | LI Tianyi, REN Yue, SONG Zhenya, JIANG Meinan, LI Mengyang, CHEN Yong, YIN Xudong. Research progress of pan-immune inflammation value in prognosis and effect of tumors[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 139-143. DOI: 10.7619/jcmp.20233348 |
[6] | JI Chao, CHEN Yixiao, LIU Kai, SU Xiaochen, TENG Menghao, GUO Yan, JI Wenchen, LI Meng. Screening of diagnostic biomarkers and their relations with immune cell infiltration in osteoporosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 1-6. DOI: 10.7619/jcmp.20231718 |
[7] | LI Yishuai, WANG Yuan, ZAHNG Lei, ZHU Longyu, QIN Xuebo, DUAN Xiaoliang, WANG Min, LI Jianhang. Expression, prognosis and immune characteristics of zinc finger CCCH domain-containing protein 12D in lung adenocarcinoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 84-92. DOI: 10.7619/jcmp.20220408 |
[8] | JU Yuejun, SHEN Ting, CHEN Gang, KONG Yinghong. Correlations between LncRNA CRNDE and prognosis, immune infiltration of papillary thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 20-24. DOI: 10.7619/jcmp.20212903 |
[9] | WEI Min, GUO Honggang, LIU Siwei, XU Fangfang, ZHANG Yin, SHI Jie, XU Zhiwei, CHEN Yuqing. Effect of immune score at initial diagnosis in predicting prognosis in patients with multiple myeloma treated with bortezomib[J]. Journal of Clinical Medicine in Practice, 2021, 25(8): 46-51. DOI: 10.7619/jcmp.20210611 |
[10] | LIU Bing, TONG Rui, LIU Jianrui, SHEN Fangchen, HONG Yueguang, LI Guangzhe, HAN Bing. Efficacy of CIK cells in the treatment of patients with advanced malignant solid tumor and the changes of tumor markers[J]. Journal of Clinical Medicine in Practice, 2016, (23): 29-31. DOI: 10.7619/jcmp.201623009 |